Controlled Clinical TrialiVNSn = 14

Safety and efficacy of neurostimulation with a miniaturised vagus nerve stimulation device in patients with multidrug-refractory rheumatoid arthritis: a two-stage multicentre, randomised pilot study

Genovese MC, Gaylis NB, Sikes D, Kivitz A, Lewis Horowitz D, Peterfy C, Glass EV, Levine YA, Chernoff D

The Lancet Rheumatology · 2020

Key finding

A miniaturised implanted vagus nerve stimulation device (MicroRegulator) was safe and well tolerated and reduced signs and symptoms in patients with multidrug-refractory RA, with once-daily stimulation showing the greatest DAS28-CRP improvement.

Condition
Rheumatoid Arthritis
Stimulation
iVNS
Evidence tier
Controlled Clinical Trial
Participants
14
View on DOI

Cite this study

Genovese, M. C., Gaylis, N. B., Sikes, D., Kivitz, A., Lewis Horowitz, D., Peterfy, C., Glass, E. V., Levine, Y. A., & Chernoff, D. (2020). Safety and efficacy of neurostimulation with a miniaturised vagus nerve stimulation device in patients with multidrug-refractory rheumatoid arthritis: a two-stage multicentre, randomised pilot study. The Lancet Rheumatology, 2(9), e527-e538. https://doi.org/10.1016/s2665-9913(20)30172-7

Related studies in Rheumatoid Arthritis

Summary by Vagus Research. Always consult the primary source for the authoritative record.

Stay Current with the Research

Join researchers and practitioners exploring the science of vagus nerve stimulation. Receive curated research summaries and evidence updates.

No spam. Unsubscribe at any time. We respect your privacy.